Back to Top Skip to main content

Military providers seek tailored approach to treating PTSD

The VA/DoD clinical practice guideline for managing post-traumatic stress disorder and acute stress disorder recommends against prescribing benzodiazepines. (U.S. Air Force photo by Airman 1st Class Joseph Pick) The VA/DoD clinical practice guideline for managing post-traumatic stress disorder and acute stress disorder recommends against prescribing benzodiazepines. (U.S. Air Force photo by Airman 1st Class Joseph Pick)

Recommended Content:

Mental Health Care | Military Hospitals and Clinics | Posttraumatic Stress Disorder

FALLS CHURCH, VA — A new reporting tool developed by the Defense Health Agency’s Pharmacy Operations Division is helping ensure Military Health System providers follow best practices in prescribing medications for patients diagnosed with post-traumatic stress disorder.

The PTS Provider Prescribing Profile lists all providers at military treatment facilities who are treating patients with PTSD or acute stress disorder, said Sushma Roberts, Ph.D., a clinical psychologist and senior program manager for DoD/VA Integrated Behavioral Health, Clinical Communities Support Section, Clinical Support Division. The tool also documents the medications providers are prescribing. 

According to the Psychological Health Center of Excellence, PTSD is a medically diagnosed mental health condition that may develop after experiencing, witnessing, or learning the details of a traumatic event such as combat, a natural disaster, sexual assault, or a terrorist attack. 

From February 2000 to February 2018, about 223,000 active-duty service members were diagnosed with PTSD, Roberts said, adding that 75 percent were diagnosed following a deployment of 30 days or longer. 

Currently, the focus is on benzodiazepines, or benzos. The clinical practice guideline released in 2017 recommended against prescribing benzos for PTSD patients, she noted. 

Benzos, also known as tranquilizers, act on the brain and central nervous system to produce a calming effect. People can easily develop a tolerance to benzos, health care experts say, needing higher doses and increased frequency to achieve the same effects. People also may suffer withdrawal symptoms, including insomnia, irritability, anxiety, panic attacks, and seizures.

It’s dangerous to combine benzos with alcohol or other medications such as opioids. In 2015, 23 percent of people who died of an opioid overdose also tested positive for benzo use, according to the Centers for Disease Control and Prevention. 

“Benzos aren’t necessarily bad,” said Army Lt. Col. Dennis Sarmiento, a psychiatrist and chair of the DHA’s Behavioral Health Clinical Community. “There are indications for their use. Short-term, they can help with anxiety, panic, and sleep. Treating such symptoms can help providers engage patients in care and better establish or reinforce rapport.”

Studies have shown a large percentage of service members and veterans who may benefit from treatment for PTSD may not seek care or complete treatment, Sarmiento said.

But medications other than benzos are recommended for treating PTSD because they’re more effective. For example, antidepressants such as Zoloft, Paxil, Prozac, and Effexor raise the brain’s level of serotonin, a chemical that reduces symptoms of depression and anxiety. 

“In contrast to benzodiazepines, these medications [antidepressants] can be used with trauma-focused psychotherapy,” Sarmiento said. Those therapies include talking or writing about traumatic events, or learning and practicing meditation or deep-breathing exercises to manage anxiety.

“Treatment should be tailored to the individual patient,” Sarmiento said. 

Sarmiento notes that throughout the MHS, benzo prescriptions have been on a downward trend since peaking in 2012. “And from available pharmacy data, we know that the medications recommended for PTSD are appropriately trending upward,” he said.

Roberts said a prototype of the reviewing and monitoring tool was developed in February 2017. It was updated in September to reflect the revised VA/DoD clinical practice guideline for the management of PTSD and acute stress disorder. The tool generates quarterly reports that the DHA Pharmacy Operations Division sends to the three service surgeon general staffs to distribute to military treatment facility leaders.

“MTF commanders have the information to know what the prescribing practices are for PTSD patients at their particular facility,” Roberts said. 

According to the tool, the number of benzos prescriptions for MHS beneficiaries diagnosed with PTSD dropped from 1,922 in the first quarter of fiscal year 2017 to 1,749 in the fourth quarter, a decline of about 9 percent. Data for the first quarter of FY 2018 was released this month. It shows the number dropped again — to 1,651.

“In June, we’ll assess trends based on second-quarter data,” Sarmiento said. “If the prescribing rate doesn’t continue declining, we’ll implement one-on-one education between clinical leadership and their high-prescribing providers.”

Meanwhile, Sarmiento encourages patients who’ve been diagnosed with PTSD to talk with their providers. “We want them to feel empowered to ask questions and understand their individual treatment plan,” he said. 


You also may be interested in...

Seizures among Active Component service members, U.S. Armed Forces, 2007 – 2016

Infographic
1/25/2018
This retrospective study estimated the rates of seizures diagnosed among deployed and non-deployed service members to identify factors associated with seizures and determine if seizure rates differed in deployment settings. It also attempted to evaluate the associations between seizures, traumatic brain injury (TBI), and post-traumatic stress disorder (PTSD) by assessing correlations between the incidence rates of seizures and prior diagnoses of TBI and PTSD. Seizures have been defined as paroxysmal neurologic episodes caused by abnormal neuronal activity in the brain. Approximately one in 10 individuals will experience a seizure in their lifetime. Line graph 1: Annual crude incidence rates of seizures among non-deployed service members, active component, U.S. Armed Forces data •	A total of 16,257 seizure events of all types were identified among non-deployed service members during the 10-year surveillance period. •	The overall incidence rate was 12.9 seizures per 10,000 person-years (p-yrs.) •	There was a decrease in the rate of seizures diagnosed in the active component of the military during the 10-year period. Rates reached their lowest point in 2015 – 9.0 seizures per 10,000 p-yrs. •	Annual rates were markedly higher among service members with recent PTSD and TBI diagnoses, and among those with prior seizure diagnoses. Line graph 2: Annual crude incidence rates of seizures by traumatic brain injury (TBI) and recent post-traumatic stress disorder (PTSD) diagnosis among non-deployed active component service members, U.S. Armed Forces •	For service members who had received both TBI and PTSD diagnoses, seizure rates among the deployed and the non-deployed were two and three times the rates among those with only one of those diagnoses, respectively. •	Rates of seizures tended to be higher among service members who were: in the Army or Marine Corps, Female, African American, Younger than age 30, Veterans of no more than one previous deployment, and in the occupations of combat arms, armor, or healthcare Line graph 3: Annual crude incidence rates of seizures diagnosed among service members deployed to Operation Enduring Freedom, Operation Iraqi Freedom, or Operation New Dawn, U.S. Armed Forces, 2008 – 2016  •	A total of 814 cases of seizures were identified during deployment to operations in Iraq and Afghanistan during the 9-year surveillance period (2008 – 2016). •	For deployed service members, the overall incidence rate was 9.1 seizures per 10,000 p-yrs. •	Having either a TBI or recent PTSD diagnosis alone was associated with a 3-to 4-fold increase in the rate of seizures. •	Only 19 cases of seizures were diagnosed among deployed individuals with a recent PTSD diagnosis during the 9-year surveillance period. •	Overall incidence rates among deployed service members were highest for those in the Army, females, those younger than age 25, junior enlisted, and in healthcare occupations. Access the full report in the December 2017 MSMR (Vol. 24, No. 12). Go to www.Health.mil/MSMR

This infographic documents a retrospective study which estimated the rates of seizures diagnosed among deployed and non-deployed service members to identify factors associated with seizures and determine if seizure rates differed in deployment settings. The study also evaluated the associations between seizures, traumatic brain injury (TBI), and post-traumatic stress disorder (PTSD) by assessing correlations between the incidence rates of seizures and prior diagnoses of TBI and PTSD.

Recommended Content:

Health Readiness | Posttraumatic Stress Disorder | Armed Forces Health Surveillance Branch | Medical Surveillance Monthly Report

Healthcare Burdens Attributable to Various Mental Disorders, U.S. Armed Forces 2016

Infographic
5/25/2017
Did you know…? In 2016, mood disorders and substance abuse accounted for 25.9% of all hospital days. Together, four mental disorders – mood, substance abuse disorders, adjustment, and anxiety – and two maternal conditions – pregnancy complications and delivery – accounted for 53.6% of all hospital bed days. And 12.4% of all hospital bed days were attributable to injuries and poisonings. Here are the mental disorders that affected U.S. Armed Forces in 2016: Pie Chart titled Bed days for mental disorders in 2016: •	Mood Disorder (46,920 bed days) – the orange pie slice. •	Substance Abuse Disorders (44,746 bed days) – the blue pie slice. •	Adjustment Disorder (30,017 bed days) – the purple pie slice. •	Anxiety Disorder (20,458 bed days) – the gray pie slice. •	Psychotic Disorder (6,532 bed days) – the light blue pie slice. •	All other mental disorders (3,233 bed days) – the violet pie slice. •	Personality disorder (2,393 bed days) – the forest green pie slice. •	Somatoform (552 bed days) – the lime green pie slice. •	Tobacco dependence (2 bed days) – the white pie slice. Bar graph shows percentage and cumulative percentage distribution, burden “conditions” that accounted for the most hospital bed days, active component, U.S. Armed Forces 2016.  % of total bed days (bars) for mood disorder, substance abuse disorders, adjustment disorder, pregnancy complications; delivery; anxiety disorder; head/neck injuries, all other digestive diseases, other complications NOS; other back problems, all other signs and symptoms; leg injuries, all other maternal conditions; all other neurologic conditions; all other musculoskeletal diseases; all other skin diseases;  back and abdomen; appendicitis; all other infectious and parasitic diseases; all other cardiovascular diseases; all other mental disorders; all other respiratory diseases; arm/shoulder injuries; poisoning, drugs; foot/ankle injuries; other gastroenteritis and colitis; personality disorder; lower respiratory infections; all other genitourinary diseases; all other malignant neoplasms; cerebrovascular disease.  See more details on this bar graph in the Medical Surveillance Monthly Report (MSMR) April 2017 Vol. 24 No. 4 report, page 4. This annual summary for 2016 was based on the use of ICD-10 codes exclusively. Read more on this analysis at Health.mil/MSMR. #LetsTalkAboutIt Background of graphic is a soldier sitting on the floor in a dark room.

This infographic documents the mental disorders that affected U.S. Armed Forces in 2016.

Recommended Content:

Armed Forces Health Surveillance Branch | Mental Health Care

Signs of Mental Health Distress

Infographic
3/3/2017
Signs of Mental Health Distress

This graphic shows signs of mental health distress.

Recommended Content:

Mental Health Care | Mental Wellness

Depression 101

Infographic
5/2/2016
Infographic about Depression symptoms and treatment

Infographic explaining the different types of depression, their symptoms and treatment options

Recommended Content:

Mental Health Care
<< < 1 > >> 
Showing results 1 - 4 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.